| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 86221 |
CAS：2125661-62-1 Butyne-DOTA |
93 |
zyl |
2024-11-22 |
| 86222 |
端乙炔基聚醚酰亚胺（PEI）（Polyetherimide，简称PEI） |
207 |
WYQ |
2024-11-22 |
| 86223 |
碳/聚硅乙炔基防热复合材料（C/PMR） |
118 |
WYQ |
2024-11-22 |
| 86224 |
聚（间二乙炔基苯-甲基氢硅烷）树脂（PSA） |
249 |
WYQ |
2024-11-22 |
| 86225 |
P-氨基苯乙炔基共轭侧基的聚对苯撑乙炔（PAnPE） |
104 |
WYQ |
2024-11-22 |
| 86226 |
DOTA-G5 DOTA修饰修饰第5代(G5)聚(酰胺基胺)树枝状聚合物 |
115 |
zcy |
2024-11-22 |
| 86227 |
DOTA-PEG5-azide 大环化合物-五聚乙二醇-叠氮 |
88 |
zyl |
2024-11-22 |
| 86228 |
1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, a-(2-carboxyethyl)-, 1,4,7,10-tetrakis(1,1-dimethylethyl) ester |
106 |
wyh |
2024-11-22 |
| 86229 |
DOTA功能化的聚赖氨酸 |
126 |
zcy |
2024-11-22 |
| 86230 |
聚乳酸-羟基乙酸共聚物-大环配体 |
122 |
wyh |
2024-11-22 |
| 86231 |
DOTA-Tyr3-thre8-奥曲肽 DOTA-Tyr3-Thre8-octreotide |
97 |
zcy |
2024-11-22 |
| 86232 |
1,4,7,10-Tetrakis(aminocarbonylmethyl)-1,4,7,10-tetraazacyclododecane |
88 |
wyh |
2024-11-22 |
| 86233 |
BKT140CXCR4 antagonist-DOTA |
102 |
zyl |
2024-11-22 |
| 86234 |
CAS:181065-46-3 p-NH2-Bn-DOTA(B-200) |
105 |
zyl |
2024-11-22 |
| 86235 |
DOTA di(tBu)ester；913542-71-9 |
110 |
wyh |
2024-11-22 |
| 86236 |
10,10'-[(5-硝基-1,3-苯基)双(亚甲基)]双[1,4,7,10-四氮杂环十二烷-1,4,7-三乙酸]，三氟乙酸盐；1175002-77-3 |
92 |
wyh |
2024-11-22 |
| 86237 |
(R)-tert-Bu4-DOTAGA；817562-90-6 |
106 |
wyh |
2024-11-22 |
| 86238 |
DOTA-Bevacizumab DOTA-贝伐单抗 |
111 |
zcy |
2024-11-22 |
| 86239 |
10-[2-[(3,5-二羧基苯基)氨基]-2-氧乙基]-1,4,7,10-四氮杂环十二烷-1,4,7-三乙酸，三氟乙酸盐 |
99 |
wyh |
2024-11-22 |
| 86240 |
DOTA接枝N-乙烯基吡咯烷酮-丙烯醛P(VP-Ac)共聚物 DOTA-VP-Ac |
103 |
zcy |
2024-11-22 |
| 86241 |
DOTA-HYNIC-IPSMA |
104 |
wyh |
2024-11-22 |
| 86242 |
PEG-GO 聚乙二醇化超小GO氧化石墨烯的二维纳米材料 |
243 |
zcy |
2024-11-22 |
| 86243 |
CAS1227407-76-2 叠氮基-单-酰胺-DOTA Azido-mono-amide-DOTA |
90 |
zyl |
2024-11-22 |
| 86244 |
(S)-N-(2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL)-2-OXOETHYL)-6-(METHYL(3-(PIPERAZIN-1-YL)PROPYL)AMINO)QUINOLINE-4-CARBOXAMIDE |
109 |
wyh |
2024-11-22 |
| 86245 |
DOTA(Tris)-EA-TEG-NH2-CBZ DOTA(Tris)-乙胺(EA)偶联四甘醇(TEG) |
186 |
zcy |
2024-11-22 |
| 86246 |
DOTA-octreotide,大环配体奥曲肽 |
129 |
zyl |
2024-11-22 |
| 86247 |
N2-Acetyl-N6-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-L-lysyl-L-prolyl-N2-methyl-L-arginyl-L-arginyl-L-prolyl-L-tyrosyl-3-methyl-L-valyl-L-leucine |
90 |
wyh |
2024-11-22 |
| 86248 |
DOTA-Ts29.2 DOTA偶联单克隆抗体Ts29.2 |
115 |
zcy |
2024-11-22 |
| 86249 |
DOTA-FAMP α螺旋肽偶联DOTA大环配体 |
108 |
zcy |
2024-11-22 |
| 86250 |
DOTA-NT8-13(靶向NTR1) |
113 |
zcy |
2024-11-22 |
| 86251 |
DOTA Conjugated JM#21 derivative 7 ；3033865-40-3 |
127 |
wyh |
2024-11-22 |
| 86252 |
4-Aminobutyl-DOTA-tris(t-butyl ester) Hexafluorophosphate |
87 |
wyh |
2024-11-22 |
| 86253 |
L-Threonine, N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-, cyclic (2→7)-disulfide |
87 |
wyh |
2024-11-22 |
| 86254 |
1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, 1-(2,5-dioxo-1-pyrrolidinyl) ester |
94 |
wyh |
2024-11-22 |
| 86255 |
DOTA-MC1RL 1，4，7，10-四氮杂环十二烷-1，4，7，10-四乙酸缀合MC1R特异性支架 |
121 |
zcy |
2024-11-22 |
| 86256 |
钆布醇杂质20 ；229312-34-9 |
141 |
wyh |
2024-11-22 |
| 86257 |
DOTA-[Nle]-cCCK 科研定制 |
135 |
zcy |
2024-11-22 |
| 86258 |
DOTA-(COOt-Bu)3-CH2-Alkynyl ；1189194-64-6 |
93 |
wyh |
2024-11-22 |
| 86259 |
FITC-PEG2-TATE ；1027160-33-3 |
115 |
wyh |
2024-11-22 |
| 86260 |
DOTA-peg4-LLP2AVLA-4 齐岳定制 |
107 |
zcy |
2024-11-22 |
| 86261 |
蛙皮素肽功能化金纳米颗粒 BBN-AuNPs |
102 |
zcy |
2024-11-22 |
| 86262 |
RGD-DOTA的结构特点 |
111 |
wyh |
2024-11-22 |
| 86263 |
DOTA tris(TBE)-amido-dPEG-bromoacetamide |
96 |
wyh |
2024-11-22 |
| 86264 |
DOTA-PEG-OPSS-AuNP DOTA-PEG-邻吡啶基二硫化物修饰纳米金纳米粒子 |
119 |
zcy |
2024-11-22 |
| 86265 |
DOTA-PEG(23)-MAL*2TFA |
95 |
wyh |
2024-11-22 |
齐岳微信公众号
官方微信
库存查询